{"database":"ENA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics","Multiomics"],"center_name":["413 Stellar Chance Lab, University of Pennsylvania"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA219056"],"scientific_name":["Homo sapiens"],"tag":["xref:PubMed:24218456"],"long_description":["In this study we compared the effects of ALK inhibitor on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from a patient with Anaplastic Large Cell Lymphoma. we used microarrays to map the genome-wide gene expression patterns in ALK+TCL cells in response to ALK inhibition. Overall design: The ALK+TCL Sudhl-1 cell line was treated in triplicates with the ALK inhibitor, CEP-14083, or the compound's solvent for 6 h. The isolated RNA was reverse-transcribed, biotin-labeled, and hybridized to the U133 Plus 2.0 array chips (Affymetrix). Microarray data were normalized using the MAS5 algorithm and analyzed using Partek GS (Partek)."],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Homo sapiens","description":"Expression of SUDHL-1 cell line treated by ALK inhibitors","dates":{"last_updated":"2025-09-22","first_public":"2014-02-11"},"accession":"PRJNA219056","cross_references":{"GEO":["GSE50803"],"taxon":["9606"],"PubMed":["24218456"]}}